JLABS

A great idea can come from anywhere. JLABS is the global incubator network of @JNJNews.

Community Guidelines:

[JLABS @JLABS]

Summer is here - what's on the calendar?

[JLABS @JLABS]

Looking forward to the exciting partnering conversations onsite and making new connections in this space. Will we see you there?

[Johnson & Johnson Innovation @JNJInnovation]

The biotech industry is driven by purpose, and next month, we’ll be joining thousands of others in the industry at BIO 2026 to discuss solutions to impossible problems, avenues to achieve better outcomes, and our ‘why’.

[JLABS @JLABS]

Join Johnson & Johnson for R&D in the age of AI — a forum on innovation, strategy, and collaboration. Hear directly from leaders, engage in Q&A, and network with industry peers. Registration is open. Don’t miss it. https://t.co/mqoVV2y8KT

[JLABS @JLABS]

Are you working on the next wave of innovation in autoimmune disease? Join us for an event focused on moving beyond inflammation control to enable deep healing. Register here: https://t.co/3u358Wm8KB

[JLABS @JLABS]

Which mental health advancement is the most critical need?

[JLABS @JLABS]

Let's move beyond inflammation control to enable deep healing: restoring tissue structure, barrier integrity and homeostatic set points for durable patient outcomes. https://t.co/3u358Wm8KB

[Johnson & Johnson Innovation @JNJInnovation]

Are you an innovator in autoimmune disease? Join J&J to explore innovations moving beyond remission, as well as collaboration opportunities to bring these to patients. Register now to join on 16 June in Brussels or virtually: https://t.co/zPuotvmpXf

[JLABS @JLABS]

Today is the day! Apply for your chance to showcase your science to J&J leadership.

Submit your big ideas aimed at changing the trajectory of neurodegenerative diseases: https://t.co/G7BoezKpq5

[Johnson & Johnson Innovation @JNJInnovation]

Last call to apply!

It’s the final day to submit your novel strategies or approaches that aim to prevent or limit the progression of neurodegenerative diseases.

Apply today: https://t.co/2gn8hLJ0vh

[JLABS @JLABS]

What area of our website do you find most beneficial?

[JLABS @JLABS]

Congratulations to the Unlocking Urologic Oncology Innovation QuickFire Challenge awardees!

Your bold innovations have the potential to reshape the future of urologic cancer treatments.

[Johnson & Johnson Innovation @JNJInnovation]

Join us in congratulating the awardees of the Unlocking Urologic Oncology Innovation QuickFire Challenge!

These innovators will receive award funding, mentorship & more to help improve treatment & care of patients with bladder & prostate cancers. https://t.co/Uy4sK1gOZY

[JLABS @JLABS]

From following the data to combining scientific fields, JLABS resident and CEO of Endura Therapeutics Adrian Sanborn is giving us his top 5 insights on the next frontier of drug discovery. Read the full blog here: https://t.co/1SMjfFOsZS

[JLABS @JLABS]

What’s happening across our JLABS? Subscribe to our Innovation newsletter to learn more about the incredible things our residents and members are doing, some upcoming opportunities, and what innovation looks like around the world: https://t.co/rKNoSPE1xC

[JLABS @JLABS]

What kind of mental health content do you find most helpful?

[JLABS @JLABS]

Despite the rising popularity of AI-driven discoveries, there is no replacing the fundamentals of innovation and drug discovery in science. Read more in our latest blog: https://t.co/XlKrwpmDZ9

[JLABS @JLABS]

In our latest blog, Prabhu Velusami, Senior Director for Search and Evaluation EMEA, outlines 5 questions he believes all startups should ask when choosing their lead clinical indication. Read more: https://t.co/UdmKuaQi9q

[JLABS @JLABS]

CEO and co-founder of JLABS resident company Endura Therapeutics, a company developing small-molecule medicines that target disease-causing proteins, is sharing 5 insights on what he believes is the next frontier of drug discovery. Read more here: https://t.co/1SMjfFOsZS

[JLABS @JLABS]

Bringing together researchers, clinicians, advocates, & women living with Alzheimer’s to listen to panel discussions & participate in conversations on the impact of advances in neuroscience was an incredible way to celebrate International Women's Day. https://t.co/CMXeyfDVaF

[JLABS @JLABS]

From strong collaborations to capital efficiency, and everything in-between: these are the 5 insights that are changing innovation in healthcare today: https://t.co/XlKrwpmDZ9

[JLABS @JLABS]

May is Mental Health Awareness Month - do you have at least one reliable way to manage stress?

[JLABS @JLABS]

Help transform the future of neurodegenerative disease research! Apply for the chance to pitch J&J leadership in London this July.

Deadline to submit: May 18 https://t.co/G7BoezKpq5

[Johnson & Johnson Innovation @JNJInnovation]

Calling all innovators! We’re looking for novel strategies or approaches that aim to prevent or limit the progression of neurodegenerative diseases.

Apply today: https://t.co/2gn8hLJ0vh

[JLABS @JLABS]

2 out of every 3 people living with Alzheimer’s disease are women. Last month, we hosted an event centered around the contributions made in Alzheimer’s research so far, and what the future of care looks like. Learn more here: https://t.co/CMXeyfDVaF